版本:
中国

BRIEF-Concert pharmaceuticals announces $30 million venture debt financing from hercules capital

June 12 Concert Pharmaceuticals Inc

* Concert pharmaceuticals announces $30 million venture debt financing from Hercules Capital

* Continue to expect to realize $160 million in connection with closing of CTP-656 asset purchase agreement with Vertex Pharmaceuticals

* Debt is in form of a secured loan, secured by concert's assets, excluding intellectual property, and bearing interest of 8.55 pct

* Loan will mature on June 1, 2021 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐